HAVCR2 and hepatocellular carcinoma: Moreover, as immune checkpoint receptors might be overexpressed in cancer, we addressed this aspect but noticed that PD-1 and TIM3 were not differently expressed in patients with active hepatocellular carcinoma (n = 4).